Skip to main content

Live BridgeBio Pharma, Inc. Common Stock Share Price Chart

O 76.65H 76.85L 76.65

BridgeBio Pharma, Inc. Common Stock Performance Overview

Days Range
▼
$76.32Low
$78.24High

Markets Today

Previous Close$76.80
Open$76.65
Volume1,575,522
Day's Range$76.32 - $78.24
52W Range$62.50 - $93.42
Market Cap$14.96 B

Historical Performance

1M Returns+14.82
3M Returns-7.08
6M Returns+18.20
1Y Returns+19.03
5Y Returns+82.91
10Y ReturnsNA

BridgeBio Pharma, Inc. Common Stock Fundamentals

Market Cap$14.96 B
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$502.08 M
ROE TTMN/A
EPS TTM$-3.04
Quarterly Earnings Growth YOYN/A
PB RatioN/A
EBITDA$-496.63 M
Profit Margin-144.39
Market Cap$14.96 B
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$502.08 M
ROE TTMN/A
EPS TTM$-3.04
Quarterly Earnings Growth YOYN/A
PB RatioN/A
EBITDA$-496.63 M
Profit Margin-144.39

BridgeBio Pharma, Inc. Common Stock Profit & Loss

Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Total Revenue +$110.56 M$120.70 M$154.18 M$194.51 M$243.68 M$353.17 M
Gross Profit +$106.91 M$114.14 M$146.07 M$184.58 M$228.63 M$332.72 M
Operating Income -$134.28 M-$145.20 M-$139.56 M-$105.96 M-$107.08 M-$11.64 M
EBITDA -$132.16 M-$134.96 M-$127.00 M-$104.77 M-$106.03 M-$10.57 M
Interest Expense -$11.61 M-$11.74 M-$11.64 M-$12.94 M-$13.28 M-$13.26 M
Depreciation $2.12 M$10.24 M$12.57 M$1.19 M$1.05 M$1.07 M
Income Before Tax -$181.66 M-$186.48 M-$194.75 M-$166.56 M-$155.89 M-$59.27 M
Income Tax Expense $2.10 M-$1.54 M-$120.00 K$0$0$1.23 M
Net Income +-$183.76 M-$184.94 M-$194.63 M-$166.56 M-$155.89 M-$60.50 M
Net Profit Margin -166.2%-153.22%-126.24%-85.63%-63.97%-17.13%

BridgeBio Pharma, Inc. Common Stock Financials Balance Sheet In USD

Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Share Capital $198.00 K$200.00 K$202.00 K$204.00 K$206.00 K$207.00 K
Reserve & Surplus -$3.45 B-$3.63 B-$3.82 B-$3.99 B-$4.14 B-$4.19 B
Non-Current Liabilities $2.68 B$2.70 B$2.72 B$2.82 B$2.83 B$2.84 B
Current Liabilities $175.85 M$216.60 M$287.97 M$816.37 M$890.65 M$977.24 M
Total Liabilities $2.86 B$2.92 B$3.01 B$3.64 B$3.72 B$3.82 B
Fixed Assets $35.62 M$34.63 M$33.44 M$32.30 M$31.87 M$30.96 M
Current Assets $912.28 M$839.38 M$797.75 M$1.24 B$1.09 B$2.04 B
Total Assets $1.08 B$998.25 M$936.02 M$1.37 B$1.22 B$2.16 B

BridgeBio Pharma, Inc. Common Stock Cash Flow

Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Net Income -$183.76 M-$184.94 M-$194.63 M-$166.56 M-$155.89 M-$60.50 M
Operating Cash Flow -$80.68 M-$109.57 M-$56.42 M-$197.28 M-$71.10 M-$44.17 M
Investing Cash Flow -$13.00 M$4.46 M-$14.35 M-$42.73 M$17.89 M$36.61 M
Financing Cash Flow $302.04 M-$894.00 K-$2.18 M$549.89 M-$148.77 M$863.01 M
Change in Cash $208.36 M-$106.00 M-$72.96 M$309.88 M-$201.98 M$855.45 M

BridgeBio Pharma, Inc. Common Stock Return Calculator

The BridgeBio Pharma, Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Returns Estimator

Based on past performance of this fund

ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$18,223
Invested Amount$10,000
Est. Returns$8,223
Invest in USA Stock Today

About BridgeBio Pharma, Inc. Common Stock

BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. Its key drug is Attruby (acoramidis), an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.

FAQs

BridgeBio Pharma, Inc. Common Stock (BBIO) share price as of November 19, 2026 is $77.72. If you are investing from India, you can always check the valuation in the INR before investing.
Yes, Indian Investors can invest in the BridgeBio Pharma, Inc. Common Stock (BBIO) Share by opening an international trading account with Angel One.
Purchasing BridgeBio Pharma, Inc. Common Stock (BBIO) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying BridgeBio Pharma, Inc. Common Stock (BBIO) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Yes, you can purchase fractional shares of BridgeBio Pharma, Inc. Common Stock (BBIO) or any other US company shares in Angel One for any dollar amount.
The market capitalization of BridgeBio Pharma, Inc. Common Stock on November 19, 2026, is $14.96 B.
BridgeBio Pharma, Inc. Common Stock operates in the Healthcare sector, specifically in the Healthcare industry.
In order to invest in BridgeBio Pharma, Inc. Common Stock (BBIO) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.